Population Pharmacodynamics of IPX066: An Oral Extended-Release Capsule Formulation of Carbidopa–Levodopa, and Immediate-Release Carbidopa–Levodopa in Patients With Advanced Parkinson’s Disease

A pharmacodynamic model is presented to describe the motor effects (tapping rate, Unified Parkinson’s Disease Rating Scale [UPDRS] Part III, and investigator-rating of ON/OFF, including dyskinesia) of levodopa (LD) in patients with advanced idiopathic Parkinson’s disease (PD) treated with immediate-...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Zhongping, Hsu, Ann, Gupta, Suneel, Modi, Nishit B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798100/
https://www.ncbi.nlm.nih.gov/pubmed/23426902
http://dx.doi.org/10.1002/jcph.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798100/
https://www.ncbi.nlm.nih.gov/pubmed/23426902
http://dx.doi.org/10.1002/jcph.63

Ejemplares similares